Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumabJavier Gállego, A. Viúdez, Raquel Hernández et al.|British Journal of Cancer|2017Cited by 49
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancerPaula Jiménez‐Fonseca, Carlos Gómez-Martín, Alberto Carmona‐Bayonas et al.|Gastric Cancer|2016Cited by 23
Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer RegistryJavier Gállego, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca et al.|Gastric Cancer|2017Cited by 20